New Delhi: Covaxin trial in the age group of 2-18 years has been cleared by the Drugs Controller General of India (DCGI) on Thursday. Bharat Biotech International Limited, Hyderabad had proposed to carry out the trial of the vaccine on the age group of 2-18 years.
In the phase Phase II/III clinical trial of the Covid vaccine will be carried out on 525 healthy volunteers by Bharat Biotech.
During the trial two vaccine doses will be injected by intramuscular route at day 0 and day 28. AIIMS (Delhi), AIIMS(Patna) and Meditrina Institute of Medical Sciences, Nagpur are the places for the trial.
Bhubaneswar: In a significant step towards strengthening climate resilience in agriculture, the Department of Agriculture…
Bhubaneswar: In a decisive step to enhance urban liveability and protect public assets, Housing &…
Bhubaneswar: The State SDG Cell of the Planning and Convergence Department, Government of Odisha, organised…
Bhubaneswar: Union Minister for Agriculture and Farmers’ Welfare and Rural Development Shivraj Singh Chouhan on Monday…
Bhubaneswar: In a move towards greater digital governance and transparency, Law, Works and Excise Minister…
Bhubaneswar: In a major push towards future-ready education, Reliance Jio, under its mission ‘AI for…
